| Results-oriented executive with extensive knowledge of the pharmaceutical and biotechnology industries. Substantial leadership, hands-on experience and proven track record from sales to the boardroom including; corporate and business development, investor relations, strategic alliances and business planning, performance management, product commercialization, and developing marketing and sales organizations. Corporate spokesperson for both private and public companies in the U.S. and Canada. A globally connected industry leader who has enjoyed considerable success as a trainer and mentor.
SELECTED ACHIEVEMENTS
Led in the strategic planning, execution and launch of multiple new drugs in Canada that collectively generated sales of over $2B in Canada since launch
Executed valuations of multiple products and companies for licensing and M & A negotiations
Spear-headed a highly successful lobbying effort for a multi-national pharmaceutical company with the provincial ministries of health that resulted in first year additions of over $30MM to provincial drug budgets
Initiated the first Hospital Pharmacy Survey with an Editorial Board of Hospital Directors to produce and launch a best practices report that became a standard for the continuous improvement of hospital pharmacy practice across Canada
Led the development and commercialization joint venture with a leading Indian pharmaceutical company leading to clinical assessment of an oncology drug for ovarian cancer
Industry spokesperson in a new therapeutic area now representing over $100MM a year in HIV drug sales
Helped create drug distribution guidelines for the Canadian drug wholesale industry
Built a new training department and implemented a company- wide training and development program which resulted in a series of successful product launches supporting the transition of an 18th position pharmaceutical company into a top ten performer with annual sales of over $100MM within five years
Designed and built a highly profitable specialized drug marketing and sales business unit within a multi-national drug company in Canada which successfully launched four specialty drugs over three years resulting in over $500MM in sales since launch
Built and led a start-up vaccine company that successfully developed a flu vaccine that led to acquisition by a larger company INCREASING shareholder value from $20MM to over $100MM in two years.
Led multiple financing initiatives which successfully raised over $60MM in venture capital to support new product development in three start-up companies including funds from government grants, venture capital firms and high net worth investors
PRIOR EXPERIENCE
Hoffmann-La Roche Canada – VP BioMedical; VP Sales Division; VP New Product Planning and Business Development
Migenix Inc. – SVP Corporate Development & CBO
Intellivax International Inc. – CEO
Cytran Inc. – President & CEO
Eli Lilly Canada – Training Manager, Product Manager, Wholesaler and Hospital Relations Mgr.
Industry Chair for: HIV/Aids Committee/Pharmaceutical Manufacturers Association of Canada; Drug Distribution Sub-Committee/Canadian Wholesale & Distribution Association; York House School – Chair, Annual Fund Campaigns
QUALIFICATIONS
University of Calgary – BSc (Biology, Biochemistry), MSc Studies (BioChemistry)
Ryerson U. and George Brown College – Marketing Studies
Duke University – Marketing Leadership Program
Roche Executive Development – finance, leadership and commercialization
Lilly Management Development – product management, training management
Canadian Investor Relations Institute – seminars and continuing education
|
